Two interesting reader comments on the issue of government-sponsored counter-detailing as discussed in yesterday's blog entry "Close(d) Encounters."
Names have been withheld to protect the intelligent:
Dear DrugWonks:
What I think is interesting is whether this will become part of P4P proposals. If the government funds these counter-detailers, what happens if a physician refuses to see them? Are they reported to CMS? Are there repercussions for those physicians? Will they get more reimbursement if they see the government counter-detailers? If generic prescribing habits are part of P4P, as some propose, will this be part of it as well. Interesting to think about.
Dear DrugWonks:
I’d want to make sure the gov't detailers have to go by the same rules as the Rx companies -- FDA approved claims, FDA approved materials, no off label etc. Isn’t more info good?
PS, good luck getting a gov't employee to get in to see a doctor without pens and pizza if they don’t have cutting edge science to share
And if pharma detailers drive up the cost of Rx, won’t their detailers do the same?
Names have been withheld to protect the intelligent:
Dear DrugWonks:
What I think is interesting is whether this will become part of P4P proposals. If the government funds these counter-detailers, what happens if a physician refuses to see them? Are they reported to CMS? Are there repercussions for those physicians? Will they get more reimbursement if they see the government counter-detailers? If generic prescribing habits are part of P4P, as some propose, will this be part of it as well. Interesting to think about.
Dear DrugWonks:
I’d want to make sure the gov't detailers have to go by the same rules as the Rx companies -- FDA approved claims, FDA approved materials, no off label etc. Isn’t more info good?
PS, good luck getting a gov't employee to get in to see a doctor without pens and pizza if they don’t have cutting edge science to share
And if pharma detailers drive up the cost of Rx, won’t their detailers do the same?
